• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

同步放化疗后,18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描对晚期III期非小细胞肺癌的早期代谢反应与局部肿瘤控制和生存相关。

Early metabolic response on 18F-fluorodeoxyglucose-positron-emission tomography/computed tomography after concurrent chemoradiotherapy for advanced stage III non-small cell lung cancer is correlated with local tumor control and survival.

作者信息

Jeong Jae-Uk, Chung Woong-Ki, Nam Taek-Keun, Song Ju-Young, Yoon Mee Sun, Kim Young-Chul, Kim Kyu-Sik, Oh In-Jae, Ban Hee-Jung, Kwon Seong Young, Bom Hee-Seung, Ahn Sung-Ja

机构信息

Department of Radiation Oncology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, 322 Seoyong-ro, Hwasun-eup, Hwasun-gun, Jeollanam-do 519-763, South Korea.

出版信息

Anticancer Res. 2014 May;34(5):2517-23.

PMID:24778069
Abstract

AIM

We evaluated the relationship of early metabolic responses on (18)F-fluorodeoxyglucose-positron-emission tomography/computed tomography (PET/CT) performed within one month after concurrent chemoradiotherapy (CCRT) with local tumor control and survival in patients with advanced stage III non-small cell lung cancer (NSCLC).

PATIENTS AND METHODS

One hundred and nineteen patients with unresectable stage III NSCLC who completed definitive CCRT were included. PET/CT was performed 2-4 weeks after completion of radiotherapy.

RESULTS

The maximum standardized uptake value (SUVmax) reduction ratio of the primary lesion (primary SRR, 80%, p<0.001), gross tumor volume (150 cm(3), p=0.036), and pre-radiotherapy ratio of SUVmax of the metastatic lymph node to that of the primary lesion (60%, p=0.05) were significantly associated with OS in multivariate analysis. The primary SRR was the only statistically significant parameter for local control.

CONCLUSION

Early metabolic response of the primary lesion after CCRT correlated with local control and overall survival in patients with unresectable stage III NSCLC.

摘要

目的

我们评估了同步放化疗(CCRT)后1个月内进行的(18)F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(PET/CT)早期代谢反应与局部肿瘤控制及晚期III期非小细胞肺癌(NSCLC)患者生存率之间的关系。

患者与方法

纳入119例完成确定性CCRT的不可切除III期NSCLC患者。放疗结束后2-4周进行PET/CT检查。

结果

多因素分析显示,原发灶最大标准化摄取值(SUVmax)降低率(原发灶SRR,80%,p<0.001)、肿瘤总体积(150 cm³,p=0.036)以及放疗前转移淋巴结SUVmax与原发灶SUVmax的比值(60%,p=0.05)与总生存期显著相关。原发灶SRR是局部控制的唯一具有统计学意义的参数。

结论

CCRT后原发灶的早期代谢反应与不可切除III期NSCLC患者的局部控制和总生存期相关。

相似文献

1
Early metabolic response on 18F-fluorodeoxyglucose-positron-emission tomography/computed tomography after concurrent chemoradiotherapy for advanced stage III non-small cell lung cancer is correlated with local tumor control and survival.同步放化疗后,18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描对晚期III期非小细胞肺癌的早期代谢反应与局部肿瘤控制和生存相关。
Anticancer Res. 2014 May;34(5):2517-23.
2
Volume-based parameters of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography improve outcome prediction in early-stage non-small cell lung cancer after surgical resection.(18)F-氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描的基于体积的参数可改善手术切除后早期非小细胞肺癌的预后预测。
Ann Surg. 2013 Feb;257(2):364-70. doi: 10.1097/SLA.0b013e318262a6ec.
3
Volume-Based Assessment With 18F-FDG PET/CT Improves Outcome Prediction for Patients With Stage IIIA-N2 Non-Small Cell Lung Cancer.基于容积的18F-FDG PET/CT评估改善ⅢA-N2期非小细胞肺癌患者的预后预测
AJR Am J Roentgenol. 2015 Sep;205(3):623-8. doi: 10.2214/AJR.14.13847.
4
Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.(18)F-FDG PET 代谢肿瘤负荷对非小细胞肺癌手术患者的预后价值。
Acad Radiol. 2013 Jan;20(1):32-40. doi: 10.1016/j.acra.2012.07.002. Epub 2012 Sep 19.
5
Value of metabolic tumor volume on repeated 18F-FDG PET/CT for early prediction of survival in locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy.代谢肿瘤体积在重复18F-FDG PET/CT上对同步放化疗治疗的局部晚期非小细胞肺癌生存早期预测的价值
J Nucl Med. 2014 Oct;55(10):1584-90. doi: 10.2967/jnumed.114.142919. Epub 2014 Sep 11.
6
The predictive value of F-FDG PET-CT for assessing the clinical outcomes in locally advanced NSCLC patients after a new induction treatment: low-dose fractionated radiotherapy with concurrent chemotherapy.F-FDG PET-CT对局部晚期非小细胞肺癌患者接受新诱导治疗(低剂量分割放疗联合同步化疗)后临床结局的预测价值
Radiat Oncol. 2017 Jan 5;12(1):4. doi: 10.1186/s13014-016-0737-0.
7
Prognostic Significance of Standardized Uptake Value of Lymph Nodes on Survival for Stage III Non-small Cell Lung Cancer Treated With Definitive Concurrent Chemoradiotherapy.接受根治性同步放化疗的Ⅲ期非小细胞肺癌患者中,淋巴结标准化摄取值对生存的预后意义
Am J Clin Oncol. 2016 Aug;39(4):355-62. doi: 10.1097/COC.0000000000000070.
8
The early predictive value of a decrease of metabolic tumor volume in repeated (18)F-FDG PET/CT for recurrence of locally advanced non-small cell lung cancer with concurrent radiochemotherapy.重复进行的(18)F-FDG PET/CT检查中代谢肿瘤体积减小对同步放化疗的局部晚期非小细胞肺癌复发的早期预测价值
Eur J Radiol. 2015 Mar;84(3):482-488. doi: 10.1016/j.ejrad.2014.11.020. Epub 2014 Dec 3.
9
Prognostic importance of F-fluorodeoxyglucose uptake by positron emission tomography for stage III non-small cell lung cancer treated with definitive chemoradiotherapy.正电子发射断层扫描中F-氟脱氧葡萄糖摄取对接受根治性放化疗的III期非小细胞肺癌的预后重要性。
Rev Esp Med Nucl Imagen Mol (Engl Ed). 2020 Jan-Feb;39(1):20-26. doi: 10.1016/j.remn.2019.04.006. Epub 2019 Oct 24.
10
Prognostic value of preoperative metabolic tumor volumes on PET-CT in predicting disease-free survival of patients with stage I non-small cell lung cancer.术前 PET-CT 代谢肿瘤体积对预测 I 期非小细胞肺癌患者无病生存的预后价值。
Anticancer Res. 2012 Nov;32(11):5087-91.

引用本文的文献

1
Evaluation of Diffusion-Weighted MRI and FDG-PET/CT to Assess Response to AdCD40L treatment in Metastatic Melanoma Patients.评估扩散加权 MRI 和 FDG-PET/CT 以评估转移性黑色素瘤患者对 AdCD40L 治疗的反应。
Sci Rep. 2019 Dec 2;9(1):18069. doi: 10.1038/s41598-019-54438-x.
2
Predicting tumor responses and patient survival in chemoradiotherapy-treated patients with non-small-cell lung cancer using dynamic contrast-enhanced integrated magnetic resonance-positron-emission tomography.使用动态对比增强整合磁共振-正电子发射断层扫描预测接受放化疗的非小细胞肺癌患者的肿瘤反应和患者生存。
Strahlenther Onkol. 2019 Aug;195(8):707-718. doi: 10.1007/s00066-018-1418-8. Epub 2019 Jan 4.
3
Predictive and prognostic value of tumor volume and its changes during radical radiotherapy of stage III non-small cell lung cancer : A systematic review.
根治性放疗中 III 期非小细胞肺癌肿瘤体积及其变化的预测和预后价值:系统评价。
Strahlenther Onkol. 2018 Feb;194(2):79-90. doi: 10.1007/s00066-017-1221-y. Epub 2017 Oct 13.
4
Role of interim F-FDG-PET/CT for the early prediction of clinical outcomes of Non-Small Cell Lung Cancer (NSCLC) during radiotherapy or chemo-radiotherapy. A systematic review.评估在放疗或放化疗期间 F-FDG-PET/CT 用于非小细胞肺癌(NSCLC)患者早期预测临床结局的作用:一项系统综述。
Eur J Nucl Med Mol Imaging. 2017 Oct;44(11):1915-1927. doi: 10.1007/s00259-017-3762-9. Epub 2017 Jul 5.
5
Influence of Surveillance PET/CT on Detection of Early Recurrence After Definitive Radiation in Stage III Non-small-cell Lung Cancer.PET/CT监测对Ⅲ期非小细胞肺癌根治性放疗后早期复发检测的影响
Clin Lung Cancer. 2017 Mar;18(2):141-148. doi: 10.1016/j.cllc.2016.11.003. Epub 2016 Nov 10.
6
The application of positron emission tomography (PET/CT) in diagnosis of breast cancer. Part II. Diagnosis after treatment initiation, future perspectives.正电子发射断层扫描(PET/CT)在乳腺癌诊断中的应用。第二部分。治疗开始后的诊断及未来展望。
Contemp Oncol (Pozn). 2016;20(3):205-9. doi: 10.5114/wo.2016.61560. Epub 2016 Aug 4.
7
Risk factors associated with recurrence of surgically resected node-positive non-small cell lung cancer.手术切除的淋巴结阳性非小细胞肺癌复发相关的危险因素。
Surg Today. 2016 Oct;46(10):1196-208. doi: 10.1007/s00595-015-1301-5. Epub 2016 Jan 19.
8
Regional Lymph Node Uptake of [(18)F]Fluorodeoxyglucose After Definitive Chemoradiation Therapy Predicts Local-Regional Failure of Locally Advanced Non-Small Cell Lung Cancer: Results of ACRIN 6668/RTOG 0235.根治性放化疗后区域淋巴结对[(18)F]氟脱氧葡萄糖的摄取可预测局部晚期非小细胞肺癌的局部区域复发:ACRIN 6668/RTOG 0235研究结果
Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):597-605. doi: 10.1016/j.ijrobp.2015.04.026.